Loading...
The ADA recommends relaxed glycemic targets for older patients with diabetes and comorbidities (Diabetes Care 2021; 44:Suppl 1:S168). In this population-based retrospective study, researchers determined drug therapies and glycemic control among 15,000 Ontario nursing home residents (mean age, 82) with type 2 diabetes who were receiving at least one glucose-lowering drug. Mean glycosylated hemoglobin (HbA1c) level was 7.3%.
On average, patients were receiving two glucose-lowering agents; about half of patients had HbA1c levels ≤7.0%. The drugs used most commonly were metformin (66%), insulin (41%), dipeptidyl dipeptidase-4 (DDP-4) inhibitors (33%), and sulfonylurea (23%). Notably, half of patients were receiving at least one high-risk agent (…